Feasibility of Short-Term Aggressive Lipid-Lowering Therapy with the PCSK9 Antibody in Acute Coronary Syndrome.
Yamashita S, Sakamoto A, Shoji S, Kawaguchi Y, Wakabayashi Y, Matsunaga M, Suguro K, Matsumoto Y, Takase H, Onodera T, Tawarahara K, Muto M, Shirasaki Y, Katoh H, Sano M, Suwa K, Naruse Y, Ohtani H, Saotome M, Urushida T, Kohsaka S, Okada E, Maekawa Y.
Yamashita S, et al. Among authors: katoh h.
J Cardiovasc Dev Dis. 2023 May 9;10(5):204. doi: 10.3390/jcdd10050204.
J Cardiovasc Dev Dis. 2023.
PMID: 37233171
Free PMC article.